Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 3/20 | 0.64 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.64 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.64 |
| ▸ | CHRNA3 | P32297 | 2/20 | 0.64 |
| ▸ | PPARG | P37231 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 4/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.51 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8841217 | 0.86 | CHRNB2 (0.68) | CHRNB2CHRNA4CHRNB4CHRNA3PPARG | |
| SCHEMBL11994154 | 0.83 | CHRNB2 (0.64) | CHRNB2CHRNA4CHRNB4CHRNA3PPARG | |
| SCHEMBL11007801 | 0.82 | CHRNB2 (0.72) | CHRNB2CHRNA4CHRNB4CHRNA3PPARG | |
| SCHEMBL7217604 | 0.79 | CHRNB2 (0.68) | CHRNB2CHRNA4CHRNB4CHRNA3PPARG | |
| SCHEMBL1649572 | 0.79 | CHRNB2 (0.68) | CHRNB2CHRNA4CHRNB4CHRNA3PPARG | |
| SCHEMBL27451737 | 0.77 | NPC1 (0.68) | KMT2AALDH1A1MEN1SMN1; SMN2 | |
| SCHEMBL1826396 | 0.77 | CHRNB2 (0.65) | CHRNB2CHRNA4CHRNB4CHRNA3HTT | |
| SCHEMBL30345390 | 0.77 | CHRNB2 (0.65) | CHRNB2CHRNA4CHRNB4CHRNA3HTT | |
| SCHEMBL28721159 | 0.77 | BCAT2 (0.57) | CHRNB2CHRNA4CHRNB4CHRNA3HTT | |
| SCHEMBL8979294 | 0.77 | CHRNB2 (0.65) | CHRNB2CHRNA4CHRNB4CHRNA3HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9735377-B2 | Phosphorescent emitters and host materials with improved stability | UNIVERSAL DISPLAY CORPORATION (US) | 2017-08-15 | — | — | US | disclosed |
| US-20170110676-A1 | PHOSPHORESCENT EMITTERS AND HOST MATERIALS WITH IMPROVED STABILITY | UNIVERSAL DISPLAY CORPORATION | 2017-04-20 | — | — | US | disclosed |
| US-20140042413-A1 | PHOSPHORESCENT EMITTERS AND HOST MATERIALS WITH IMPROVED STABILITY | UNIVERSAL DISPLAY CORPORATION (US) | 2014-02-13 | — | — | US | disclosed |
| US-8586204-B2 | Phosphorescent emitters and host materials with improved stability | UNIVERSAL DISPLAY CORPORATION (US) | 2013-11-19 | — | — | US | disclosed |
| US-20110057559-A1 | PHOSPHORESCENT EMITTERS AND HOST MATERIALS WITH IMPROVED STABILITY | UNIVERSAL DISPLAY CORPORATION (US) | 2011-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110057559-A1 | PHOSPHORESCENT EMITTERS AND HOST MATERIALS WITH IMPROVED STABILITY | DDT, TPST2, NUDT1 | CHRNB2 4226/4885CHRNA4 4520/4885CHRNB4 4349/4885 |
| US-20170110676-A1 | PHOSPHORESCENT EMITTERS AND HOST MATERIALS WITH IMPROVED STABILITY | NUDC, TEC, MAP1LC3C | CHRNB2 3986/4885CHRNA4 3810/4885CHRNB4 4098/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.